Pharmaceutical production in Russia and the CIS

Pharma IQ presents to you the latest event in its international series – the forum "Pharmaceutical Production in Russia and the CIS", which will be held on September 18-20, 2012 in Moscow.

According to analysts' forecasts, the total turnover of the Russian pharmaceutical market will amount to 37.15 billion US dollars in 2016, and the Pharma 2020 strategy will attract 4 billion US dollars of public investment. In this regard, the tasks of increasing productive capacity and improving the efficiency of production processes have become priority areas of activity of key market participants.

In accordance with the Pharma 2020 strategy, the government intends to provide financial support to existing pharmaceutical companies in carrying out research and development aimed at increasing the volume of innovative medicines produced and stimulating the development of new domestic companies.

The most important goal of the strategy is to increase the number of medicines produced by Russian companies to 50% by 2020, while 80% of this volume should be innovative medicines. Many international market participants plan to build their own manufacturing enterprises in the region or produce medicines using pharmaceutical outsourcing, which will allow them to take advantage of the profitable opportunities offered by the market.

Become a participant of the forum and master classes, and you will be able to get acquainted with the most influential players in the pharmaceutical market of Russia and CIS countries, expand your knowledge of advanced methods used in the production of medicines in Russia, Europe and other regions.

Details are available on the forum's website.

Portal "Eternal youth" http://vechnayamolodost.ru18.05.2012